Cardiology
Conference Coverage
Diuretic agents equal to prevent CV events in hypertension: DCP
Cardiovascular events were nearly identical with two different hypertension drugs in the randomized Diuretic Comparison Project trial.
Conference Coverage
Triglyceride-lowering fails to show CV benefit in large fibrate trial
In the phase 3 PROMINENT trial, pemafibrate improved multiple lipid fractions in patients with type 2 diabetes, without any impact on...
Conference Coverage
Uptake of high-sensitivity troponin assays lags in U.S. hospitals
A national analysis found that only one-third of hospitals are utilizing the assays, despite the first test being approved in 2017.
News
Best anticoagulant for minimizing bleeding risk identified
“Apixaban stood out as having lower risk of gastrointestinal bleeding.”
News
Kidney function may help docs pick antiplatelet mix after stroke
Ticagrelor–aspirin compared with clopidogrel-aspirin reduced risk for recurrent stroke with no substantial increase in severe or moderate bleeding...
News
Diet high in plant omega-3s tied to better HF prognosis
Heart failure patients with higher circulating alpha-linolenic acid levels were at lower risk of hospitalization and death.
News
IV potassium and magnesium an acute treatment for AFib?
“It’s simple, inexpensive, you make the heart rate go back to normal, not permanently, with few side effects, except perhaps for some pain at the...
News
Finerenone: ‘Striking’ cut in pneumonia, COVID-19 risks
Secondary analyses of the finerenone pivotal trials showed that the agent was linked with less infective pneumonia and blunted COVID-19 severity...
News
Study reveals racial disparities in advanced HF therapies
White adults were twice as likely as Black adults to receive a ventricular assist device or heart transplant.
News
Four commonly abused drugs linked with atrial fibrillation
All four drugs – cocaine, methamphetamine, opioids, and cannabis – whether stimulants or depressants – cause “quite dramatic and often rapid...